Sigma(R) Life Science Joins EMBL Advanced Training Centre Corporate Partnership Programme
ST.
Read more on redOrbit
Sigma(R) Life Science Joins EMBL Advanced Training Centre Corporate Partnership Programme
March 29, 2010 By Leave a Comment
Arena Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of APD916 For Narcolepsy And Cataplexy
March 29, 2010 By Leave a Comment
Arena Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of APD916 For Narcolepsy And Cataplexy
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy. “There is a need for better tolerated, more effective therapies for narcolepsy, especially narcolepsy with cataplexy,” said William R …
Read more on Medical News Today
GlaxoSmithKline, Pfizer Will Supply 600M Doses Of Reduced-Price Pneumococcal Vaccines To Developing Countries Over 10 …
March 29, 2010 By Leave a Comment
GlaxoSmithKline, Pfizer Will Supply 600M Doses Of Reduced-Price Pneumococcal Vaccines To Developing Countries Over 10 …
The GAVI Alliance on Tuesday formally announced that drugmakers GlaxoSmithKline and Pfizer had signed off on a “10-year deal … to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations,” Reuters reports. The agreement is under what’s “called an Advance Market Commitment (AMC) which guarantees a market for vaccines supplied to poor nations but sets a maximum …
Read more on Medical News Today
Vaccine deal signed – 47 developing countries to receive low priced vaccines by 2015
March 28, 2010 By Leave a Comment
Vaccine deal signed – 47 developing countries to receive low priced vaccines by 2015
Pharmaceutical giants have signed a historical 10-year deal on Tuesday pledging the supply of 60 million doses a year of pneumococcal vaccines at cut-prices to developing nations.
Read more on News-Medical-Net
Orasi Medical close to inking major licensing deal(s) with Big Pharma
March 28, 2010 By Leave a Comment
Orasi Medical close to inking major licensing deal(s) with Big Pharma
Orasi Medical Inc., the University of Minnesota spin-out developing software to speed drug trials, is close to signing a deal to license its technology to one or more major pharmaceutical companies. CEO Shawn Lyndon told MedCity News he expects to announce a deal in a month or so. Though Lyndon declined to specifically name companies, he [...]
Read more on MedCity News